BioSpace News Archive

Global Bronchitis Drugs Market 2018-2022| Use of Off-Label Drugs for Bronchitis to Boost Growth | Technavio

The global bronchitis drugs market is expected to post a CAGR of close to 4% during the period 2018-2022, according to the latest market research report by Technavio

January 4, 2019
·
4 min read
Business

Perception Health On AWS Marketplace Machine Learning And Artificial Intelligence Discovery Page

Perception Health, a leading provider of healthcare market prediction software, announced today their inclusion on the new machine learning (ML) and artificial intelligence (AI) discovery page on AWS Marketplace.

January 4, 2019
·
2 min read
BioMidwest

Minnesota Dental Association Recommends Making a New Year’s Resolution for a Healthier Mouth

Tips for improving your oral health in 2019

January 4, 2019
·
1 min read
Deals

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) on January 4, 2019

Curis, Inc. announced that on January 2, 2019, the independent Compensation Committee of the Board of Directors of Curis approved the grant of inducement stock options to purchase 30,000 shares of Curis common stock to a new employee, with a grant date of January 2, 2019

January 4, 2019
·
5 min read
Genetown

Quanterix Marks One-Year Anniversary of IPO with Key Milestones Accelerating Healthcare Disruption Ahead of Presentation at the 37th Annual J.P. Morgan Healthcare Conference

Company celebrates remarkable growth in 2018 fueled by new product launches, acceleration of ground-breaking publications and rapid adoption of digital biomarkers in neurology and oncology research

January 4, 2019
·
6 min read
Deals

Acreage Holdings Acquires Nature’s Way Nursery of Miami, Inc.

Acreage Holdings, Inc. announced it has closed the acquisition of Florida-based Nature’s Way Nursery of Miami, Inc.

January 4, 2019
·
5 min read
Pharm Country

Amring Pharmaceuticals Announces 2018/19 Launches

Amring Pharmaceuticals Inc. announced today that it launched a generic oncology drug, Arsenic Trioxide Injection in November 2018 and expects to launch four (4) additional generic drugs in 2019.

January 4, 2019
·
2 min read
Job Trends

GeneSight® GUIDED Study Published in the Journal of Psychiatric Research

Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, todayannounced the publication of the landmark GeneSight GUIDED study in the Journal of Psychiatric Research

January 4, 2019
·
9 min read
Business

Esperion Announces Agreement with Daiichi Sankyo Europe (DSE) to Commercialize Bempedoic Acid in Europe

Esperion Therapeutics (NASDAQ: ESPR) today announced that they have entered into a licensing agreement with Daiichi Sankyo Europe (DSE) providing DSE with exclusive rights to commercialize bempedoic acid and the bempedoic acid / ezetimibe combination pill in the European Economic Area and Switzerland.

January 4, 2019
·
8 min read
Lamellar to conduct multiple Business Development Meetings about its LAMELLASOME™ technology for safe and effective delivery of nucleic-acid based therapeutics at Biotech Showcase in San Francisco

Lamellar Biomedical Limited (Lamellar), an innovative biotechnology company, pioneering new approaches for the safe and effective transfer of functional nucleic acids, announces that Dr Alec McLean, CEO; Steven Porteous, Head of Clinical and Regulatory and Dr Lynsey Howard, Head of Pre-clinical Development will be attending Biotech Showcase in San Francisco 7 -9

January 4, 2019
·
4 min read